Novo Nordisk Aktie - NOVA

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Premium

Current Price

98,60

Gebot

98,20

Fragen

98,40

Volumen

6.107

96,60 Tagesbereich 100,50

0,00 52-Wochen-Bereich 0,00

Marktkapitalisierung

439,976B

Handelsende

100,00

Handelsbeginn

100,00

Letzte Trade

98.6

Letzter Handelszeitpunkt

20:38:25

Finanzvolumen

VWAP

Durchschnittliches Volumen (3 Mio.)

Ausgegebene Aktien

4.462.229.293

Dividendenrendite

Kurs-Gewinn-Verhältnis

5,52

Gewinn pro Aktie (EPS)

18,75

Erlöse

232,26B

Nettogewinn

83,68B

Sektor

Pharmaceutical Preparations

Branche

Pharmaceutical Preparations

Website

www.novonordisk.com

Hauptsitz

Bagsvaerd, Dnk

Gegründet

Novo Nordisk is listed in the Pharmaceutical Preparations sector of the Tradegate (DE) with ticker NOVA. The last closing price for Novo Nordisk was 100,00 €. Over the last year, Novo Nordisk shares have traded in a share price range of 0,00 € to 0,00 €.

Novo Nordisk currently has 4.462.229.293 shares in issue. The market capitalisation of Novo Nordisk is 446,22 € billion. Novo Nordisk has a price to earnings ratio (PE ratio) of 5.52.

Success of the Simplified Cash Tender Offer for the Shares & bons de souscription d’actions of Novagali Pharma SA by Santen...

Regulatory News: Santen Pharmaceutical Co., Ltd. (“Santen”) and Novagali Pharma SA (“Novagali”) announced today the success of the simplified cash tender offer for the...

Novagali Pharma: Revenue for the 3rd quarter of 2011

Regulatory News: Novagali Pharma (Paris:NOVA), a pharmaceutical company that develops and markets innovative ophthalmic products, today announces its revenue for the first...

Santen Pharmaceutical Co., Ltd. Completes the Acquisition of a Controlling Interest in Novagali Pharma S.A.

Regulatory News: Following the press release of September 28, 2011, in accordance with articles 223-2 and 223-6 of the general regulations of the French Autorité des...

Signing of an Acquisition of a Controlling Interest in Novagali Pharma S.A. by Santen Pharmaceutical Co., Ltd.

Regulatory News: Santen Pharmaceutical Co., Ltd. (Osaka, Ticker Code 4536JP) (hereafter “Santen”), a leading Japanese pharmaceutical company, and Novagali Pharma S.A...

Novagali Pharma Reports Positive Results in Phase II Study for Catioprost® vs. Travatan Z® in Patients with Glaucoma & Ocul...

Regulatory News: Novagali Pharma (Paris:NOVA) announced today US phase II positive results on the efficacy and safety of Catioprost® in patients with glaucoma and...

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

Volumen
% Tops
% Flops

Symbol	Preis	Vol.
0S6Cerence Inc	5,98 € (123,05%)	71,21k
7S2Scotch Creek Ventures Inc	0,0144 € (67,44%)	5,61k
AOYAlpha and Omega Semiconductor Ltd	38,98 € (35,25%)	2,15k
ID4Recylico Battery Materials Inc	0,095 € (32,68%)	8,18k
5Q5Snowflake Inc	162,44 € (32,50%)	85,76k
BVU3St James Gold Corp	0,048 € (-54,72%)	250
AAJ0Perspective Therapeutics Inc	2,84 € (-51,45%)	970
9S70Critical Resources Limited	0,002 € (-50,00%)	5k
L7C2Windfall Geotek Inc	0,003 € (-45,45%)	16k
20MPMountain Valley MD Holdings Inc	0,0116 € (-38,95%)	39,5k
D7GNel ASA	0,2502 € (-7,98%)	16,36M
P1MPeninsula Energy Limited	0,0365 € (-1,08%)	6,33M
GHUADX Energy Ltd	0,0334 € (-17,33%)	2,13M
NVDNVIDIA Corp	141,14 € (1,94%)	1,48M
BT81PowerHouse Energy Group Plc	0,0122 € (0,00%)	1,11M

Foren

Foren anzeigen

Keine Diskussionen Gefunden.

Neuen Thread Erstellen

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Novo Nordisk (NOVA)

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Wichtige Statistiken und Details

Über Novo Nordisk

NOVA Neueste Nachrichten

Success of the Simplified Cash Tender Offer for the Shares & bons de souscription d’actions of Novagali Pharma SA by Santen...

Novagali Pharma: Revenue for the 3rd quarter of 2011

Santen Pharmaceutical Co., Ltd. Completes the Acquisition of a Controlling Interest in Novagali Pharma S.A.

Signing of an Acquisition of a Controlling Interest in Novagali Pharma S.A. by Santen Pharmaceutical Co., Ltd.

Novagali Pharma Reports Positive Results in Phase II Study for Catioprost® vs. Travatan Z® in Patients with Glaucoma & Ocul...

Novagali: Availability of the 2011 half-year financial report

Novagali: 2011 First-Half Results

Novagali : Revenue for the first half of 2011

Novagali Pharma: Supervisory Board Strengthened Significantly

Novagali Pharma and Ardeo Sign an Exclusive Distribution Agreement for Nova23041 in the United States and Canada

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

Trends

Toplisten

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Novo Nordisk (NOVA) Börsenkurse

Novo Nordisk (NOVA)

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Wichtige Statistiken und Details

Über Novo Nordisk

NOVA Neueste Nachrichten

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE